2021 - 2024 Prognostic prediction of Behcet disease based on clinical clustering factors
2019 - 2024 Generation of evidence through registry construction by genome-wide subtype analysis of Behcet's disease
2021 - 2024 ベーチェット病の病態解明および治療法開発を目的とした全国レジストリの構築
2020 - 2023 ベーチェット病に関する調査研究
2019 - 2022 The pathological role of autoantibodies in systemic lupus erythematosus
2017 - 2020 cluster analysis
2014 - 2017 The ubiquitylation system as a potential therapeutic target for rheumatic diseases
2014 - 2017 Impaired M2 macrophage function in Behcet's disease as a therapeutic target
2013 - 2016 The mechanism of dysregulation of inflammation in systemic lupus erythematosus
2011 - 2013 Regulatory roles of heme oxygenase-1 in autoinflammation and autoimmunity as a model of Behcet's disease
2008 - 2010 A epidemiological study of long-term safety of biological disease-modifying antirheumatic drugs for patients with rheumatoid arthritis and risk factors for adverse drug reactions.
2008 - 2010 Regulation of heme oxygenase-1 expression and the therapeutic application in rheumatic and inflammatory diseases
2004 - 2005 Role of an anti-inflammatory protein, heme oxygenase-1 in rheumatic and inflammatory diseases
2002 - 2003 Roles of Toll like receptor in the development of autoimmune diseases
2002 - 2002 新規のヒトTh1型サイトカイン特異的転写因子、Txkの機能解析
2000 - 2001 Development of novel therapeutic strategies for rheumatoid arthritis based on the neuro - endocrine-immune axis
2000 - 2000 全身性エリテマトーデスの発症のメカニズムと女性のX染色体キメリズム
1998 - 1999 Fas ligands peripheral lymphocytes from patients with systemic lupus erythematosus
1998 - 1999 X-chromosome inactivation mosaicism is implicated in the emergence of autoreactive T cells in patients with systemic lupus erythematosus
1998 - 1998 HIV感染による宿主側免疫機構の破綻とその制御
1994 - 1994 Th1型細胞への分化誘導によるアレルギー炎症の制御
1994 - 1994 全身性エリテマトーデスにおける病原性T細胞の同定とその分子生物学的性状解析
1993 - 1993 SLEにおける病原性T細胞の分子生物学的アプローチによる性状解析
1992 - 1992 ヒト全身性エリテマトーデスにおけるCD4^+T細胞異常の病因的意義
1990 - 1991 Cytokine production pattern of CD4+ T cells and its relation to anti-DNA antibody production in patients with systemic lupus erythematosus
Shunsei Hirohata, Hirotoshi Kikuchi, Tetsuji Sawada, Masataka Kuwana, Izumi Kawachi, Yohei Kirino, Yoshiaki Ishigatsubo, Mitsuhiro Takeno. Effect of Infliximab on Chronic Progressive Behcet's Disease: Influence of the Timing of Introduction on the Patient Outcome. Internal medicine (Tokyo, Japan). 2023
Hiroko Nagafuchi, Hirotoshi Kikuchi, Hiroyuki Ishibash, Hideaki Maeda, Hitoshi Ogino, Yohei Kirino, Tetsuji Sawada, Kazuyoshi Saito, Masataka Kuwana, Shunsei Hirohata, et al. Recommendations for the management of the vascular involvement in Behçet's disease by the Japanese national research committee for Behçet's disease-secondary publication. Modern rheumatology. 2023
Ayana Suzuki, Koichiro Kamio, Mitsuhiro Takeno, Yasuhiro Terasaki, Namiko Taniuchi, Junpei Sato, Nobuhiko Nishijima, Yoshinobu Saito, Masahiro Seike, Akihiko Gemma, et al. Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review. Therapeutic advances in respiratory disease. 2023. 17. 17534666231158279-17534666231158279
日本臨床リウマチ学会
, THE JAPAN SOCIETY FOR CLINICAL IMMUNOLOGY
, THE JAPANESE SOCIETY FOR IMMUNOLOGY
, JAPANESE SOCIETY OF ALLERGOLOGY
, JAPAN COLLEGE OF RHEUMATOLOGY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
